Evaluation of Prognosis and Risk Factors of Fulminant Myocarditis Complicated with Malignant Arrhythmia
Journal of Cardiovascular Development and Disease · 24.12.2025 · 13 (1) · 14
DOI: 10.3390/jcdd13010014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 24.12.2025. Verfasst von Yanan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan 430030, …. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project.
Abstract (Originalsprache)
(1)
Background
Malignant arrhythmia complicating fulminant myocarditis is associated with high in-hospital mortality, but evidence regarding its long-term prognosis and specific risk factors is limited. (2)
Methods
This single-center retrospective cohort study (2016–2025) analyzed 241 consecutive fulminant myocarditis patients, stratified by malignant arrhythmia status (n = 58 vs. 183). The malignant arrhythmia group was further subclassified into malignant tachyarrhythmia (n = 22) and bradyarrhythmia (n = 36). Endpoints included major adverse cardiovascular events (MACE), cardiac dysfunction, and structural abnormalities. (3)
Results
At 3-month follow-up, malignant arrhythmia patients had a significantly higher incidence of MACE compared to non-malignant arrhythmia patients (15.5% vs. 4.9%, p = 0.008), but no significant differences were found in cardiac dysfunction or structural abnormalities. Multivariate analysis identified low triglyceride level as an independent risk factor for in-hospital malignant tachyarrhythmia. For in-hospital malignant bradyarrhythmia, independent risk factors were delayed, such as intrinsicoid deflection, low diastolic blood pressure, bradycardia, and an elevated E/Em ratio, with the predictive model showing high discriminatory power. (4)
Conclusions
Malignant arrhythmia is an independent predictor of adverse short-term, but not long-term, prognosis in fulminant myocarditis patients, with distinct risk factor profiles identified for malignant tachyarrhythmia and malignant bradyarrhythmia subtypes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan 430030, China.
ORCID-Profile: Jialin Zang
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
Zitieren
APA
Wang, Y., Zang, J., Li, G., Li, Z., Wang, L., & Jiang, J. (2025). Evaluation of Prognosis and Risk Factors of Fulminant Myocarditis Complicated with Malignant Arrhythmia. Journal of Cardiovascular Development and Disease, 13(1), 14. https://doi.org/10.3390/jcdd13010014
Vancouver
Wang Y, Zang J, Li G, Li Z, Wang L, Jiang J. Evaluation of Prognosis and Risk Factors of Fulminant Myocarditis Complicated with Malignant Arrhythmia. Journal of Cardiovascular Development and Disease. 2025;13(1):14. doi:10.3390/jcdd13010014
BibTeX
@article{Wang2025,
author = {Wang, Yanan and Zang, Jialin and Li, Guangling and Li, Zeping and Wang, Luyun and Jiang, Jiangang},
title = {Evaluation of Prognosis and Risk Factors of Fulminant Myocarditis Complicated with Malignant Arrhythmia},
journal = {Journal of Cardiovascular Development and Disease},
year = {2025},
volume = {13},
number = {1},
pages = {14},
doi = {10.3390/jcdd13010014}
}
EUVIMED